Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02408173
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NNR | Nicotinamide riboside | A | 2QT0 | 0.8 | |
NNR | Nicotinamide riboside | A | 2QT1 | 0.8 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B | 2QTN | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4F | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4L | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D | 1YUM | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4M | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D,E,F | 1QPN | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C | 2B7Q | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4K | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4G | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1YTK | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4H | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L5O | 0.74 | |
DR7 | (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)- 8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)- 6-[[4-(2-PYRIDINYL)PHENYL]METHYL]- 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER | B | 2AQU | 0.74 | |
DR7 | (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)- 8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)- 6-[[4-(2-PYRIDINYL)PHENYL]METHYL]- 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER | A | 2FXD | 0.74 | |
DR7 | (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)- 8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)- 6-[[4-(2-PYRIDINYL)PHENYL]METHYL]- 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER | A | 2O4K | 0.74 | |
DR7 | (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)- 8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)- 6-[[4-(2-PYRIDINYL)PHENYL]METHYL]- 2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER | A,B | 2FXE | 0.74 | |
NA3 | (3S)-3-{[(5-BROMOPYRIDIN-3-YL)CARBONYL]AMINO}- 4-OXOBUTANOIC ACID | A | 1RE1 | 0.72 | |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.75 | |
GGW | methyl [(1S,4S,5S,7S,10S)-4-benzyl- 1,10-di-tert-butyl-5-hydroxy-2,9,12- trioxo-7-(4-pyridin-2-ylbenzyl)- 13-oxa-3,8,11-triazatetradec-1- yl]carbamate | H | 3GGA | 0.71 | |
LIQ | N-{(1S)-2-({(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 3-[(3-ETHYLBENZYL)AMINO]-2-HYDROXYPROPYL}AMINO)- 2-OXO-1-[(PENTYLSULFONYL)METHYL]ETHYL}NICOTINAMIDE | A | 2HM1 | 0.71 | |
2AH | B | 2CEM | 0.71 | ||
BLP | (5-HYDROXY-6-METHYL-4-((2-(2-(2- NITROBENZAMIDO)ACETYL)HYDRAZINYL)METHYL)PYRIDIN- 3-YL)METHYL DIHYDROGEN PHOSPHATE | A,B | 2GQN | 0.7 | |
BEJ | N,N-[2,5-O-[DI-4-PYRIDIN-3-YL-BENZYL]- GLUCARYL]-DI-[VALYL-AMIDO-METHANE] | B | 1EC2 | 0.71 | |
MS3 | N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI- [VALINYL-AMINOMETHANYL-PYRIDINE] | A | 1EC3 | 0.72 | |
TIT | N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]- 3-HYDROXY-4-{[N-(PYRIDIN-2-YLCARBONYL)- L-VALYL]AMINO}PENTANOYL)-L-ALANYL- L-LEUCINAMIDE | A,B | 1W6H | 0.7 | |
475 | N-[oxo(pyridin-2-ylamino)acetyl]- beta-D-glucopyranosylamine | A | 3CUV | 0.72 | |
1IN | 1-[2-HYDROXY-4-(2-HYDROXY-5-METHYL- CYCLOPENTYLCARBAMOYL)5-PHENYL-PENTYL]- 4-(3-PYRIDIN-3-YL-PROPIONYL)-PIPERAZINE- 2-CARBOXYLIC ACID TERT-BUTYLAMIDE | B | 2BPV | 0.73 | |
1IN | 1-[2-HYDROXY-4-(2-HYDROXY-5-METHYL- CYCLOPENTYLCARBAMOYL)5-PHENYL-PENTYL]- 4-(3-PYRIDIN-3-YL-PROPIONYL)-PIPERAZINE- 2-CARBOXYLIC ACID TERT-BUTYLAMIDE | B | 2BPW | 0.73 | |
DL8 | N-[(4-PHENYL-1H-1,2,3-TRIAZOL-1- YL)ACETYL]-BETA-D-GLUCOPYRANOSYLAMINE | A | 2PYI | 0.71 | |
4AH | B | 2CEN | 0.72 | ||
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 2QSZ | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 1TA8 | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 1HYB | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 3BAA | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 3BA9 | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 1NUP | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 1NUS | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 1Y1P | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B,C,D,E,F | 2GVG | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 3BA8 | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 3BAB | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 3DZK | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B,C | 1GZU | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 2H3D | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 2G96 | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A | 2QG6 | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 1ISJ | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 3DZJ | 0.78 | |
NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | A,B | 2HCT | 0.78 | |
NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.71 |